Sujet(s)
Antiviraux/usage thérapeutique , Transplantation de microbiote fécal , Antigènes e du virus de l'hépatite virale B/analyse , Hépatite B chronique/thérapie , Hépatite B chronique/virologie , Adulte , Études cas-témoins , Femelle , Microbiome gastro-intestinal/immunologie , Hépatite B chronique/immunologie , Humains , MâleRÉSUMÉ
The pathogenesis of colon cancer (Cca) is to be further investigated. Vitamin D deficiency is associated with cancer growth; the underlying mechanism is unclear. Published data indicate that Cca cells express CD23. This study tests a hypothesis that exposure to IgE induces Cca cell apoptosis. In this study, the effect of ligation of CD23 by IgE on the expression of cyp27b1 was performed with Cca cells. The induction of apoptosis of Cca cells by IgE was assessed in a cell culture model. We observed that Cca cells express CD23; ligation of CD23 with IgE on Cca cells increased the expression of cyp27b1 in Cca, which promoted the conversion of VD3 to calcitriol, the latter increased the expression of FasL by Cca cells, and induced apoptosis of Cca cells. In conclusion, IgE is capable of inducing the cancer cell apoptosis via ligating CD23 and converting VD3 to calcitriol. The results suggest that IgE may have therapeutic potential in the treatment of Cca.
RÉSUMÉ
Behçet's disease is a chronic, relapsing, systemic vasculitis of unknown aetiology. Patients present manifestations of gastrointestinal complications, including mouth lesions, small and large intestinal lesions, and vascular lesions in the abdomen. In some cases, the intestinal ulcers of patients with Behçet's disease are indistinguishable from those of Crohn's disease, tuberculosis, vasculitis and other diseases. In this article, we present a case of atypical Behçet's disease with a complicated medical history and multisystem damage, for the purpose of better management of this disease.
Sujet(s)
Maladie de Behçet/diagnostic , Maladie de Behçet/anatomopathologie , Côlon/anatomopathologie , Muqueuse intestinale/anatomopathologie , Vascularite/diagnostic , Angiographie de soustraction digitale , Biopsie , Coloscopie , Diagnostic différentiel , Diarrhée/diagnostic , Endoscopie , Humains , Inflammation , Imagerie par résonance magnétique , Mâle , Adulte d'âge moyen , Récidive , Résultat thérapeutique , Ulcère/diagnostic , Ulcère/anatomopathologieRÉSUMÉ
The aim of this study was to investigate the effect of aplasia ras homolog member I (ARHI) on proliferation, apoptosis and the cell cycle in the pancreatic cancer cell line PANC-1. The study also aimed to examine the effect of ARHI on the activity of the nuclear factor (NF)-κB and to determine whether ARHI acts as a tumor suppressor in the development of pancreatic cancer by inhibiting the activity of NF-κB. A pIRES2EGFPARHI vector, constructed by reverse transcrition (RT)PCR, was transiently transfected into the PANC-1 cells and analyzed for the expression of the ARHI protein by western blotting. A MTT assay was used to quantify cell proliferation, and apoptosis was analyzed by flow cytometry. The NFκB signaling pathway, specifically the pathway using the nuclear phosphorylated p65 isoform, was analyzed by western blotting. Expression of the ARHI protein was detected by western blotting subsequent to the PANC-1 cells being transiently transfected with the pIRES2EGFPARHI construct. Cell proliferation was strongly inhibited in the PANC-1 cells transfected with pIRES2EGFPARHI. The cell cycle assays indicated an increase in the number of cells at the G0/G1 phase and a decrease in the cells at the S phase, but the difference was not significant (P>0.05). Time course studies also indicated a marked increase in the apoptotic index following transient transfection, as well as a gradual decrease in the expression of the nuclear phosphorylated p65 protein. ARHI acts as a tumor suppressor by downregulating the NFκB signaling pathway, which results in the inhibition of cell proliferation, apoptosis and the cell cycle in the pancreatic tumor PANC-1 cell line.